TrianglePUBLICATIONS · 34219000
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2021 Aug
- First author
- Miles D
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Miles D
- type
- Author
- name
- Gligorov J
- type
- Author
- name
- André F
- type
- Author
- name
- Cameron D
- type
- Author
- name
- Schneeweiss A
- type
- Author
- name
- Barrios C
- type
- Author
- name
- Xu B
- type
- Author
- name
- Wardley A
- type
- Author
- name
- Kaen D
- type
- Author
- name
- Andrade L
- type
- Author
- name
- Semiglazov V
- type
- Author
- name
- Reinisch M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Miles D
- type
- Author
- name
- Gligorov J
- type
- Author
- name
- André F
- type
- Author
- name
- Cameron D
- type
- Author
- name
- Schneeweiss A
- type
- Author
- name
- Barrios C
- type
- Author
- name
- Xu B
- type
- Author
- name
- Wardley A
- type
- Author
- name
- Kaen D
- type
- Author
- name
- Andrade L
- type
- Author
- name
- Semiglazov V
- type
- Author
- name
- Reinisch M
- type
- Author
- bibliography ids
- nci-bib-76e729ac26a308423ee89a12
- book metadata
- content sha256
- bbe6eaad79e6a0b11aff095f77507cbaa3140f89701f93596a4d09aa3584eb25
- document type
- citation
- dois
- 10.1016/j.annonc.2021.05.801
- electronic publication date
- display
- 2021 Jul 1
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34219000
- immutable id
- pubmed:34219000@bbe6eaad79e6a0b11aff095f77507cbaa3140f89701f93596a4d09aa3584eb25
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 8
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 994-1004
- volume
- 32
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34219000
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- bad3aaecbb2612ea9a3b346adabf74abdfa02213c5d3f82331e137804c8e2d5f
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Aug
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.
Preserved source evidence · Not medical advice